Literature DB >> 2969825

Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study.

F de Lalla1, E Rinaldi, D Santoro, G Pravettoni.   

Abstract

Two-hundred-ninety-nine hospital workers were randomly allocated to receive MSD hepatitis B vaccine in different injection sites and by different routes (intramuscularly by gluteal or deltoid injections or subcutaneously in the arm) or Pasteur vaccine subcutaneously. Highest rates of seroconversion and highest mean anti-HB, titres were found in subjects given MSD vaccine by intramuscular injection into the deltoid muscle.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969825     DOI: 10.1007/bf00144763

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  5 in total

1.  Site of injection and response to hepatitis B vaccine.

Authors:  T Ukena; H Esber; R Bessette; T Parks; B Crocker; F E Shaw
Journal:  N Engl J Med       Date:  1985-08-29       Impact factor: 91.245

2.  Suboptimal response to hepatitis B vaccine given by injection into the buttock.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-03-01       Impact factor: 17.586

3.  Response to deltoid muscle injection of hepatitis B vaccine after failure to respond to gluteal injections.

Authors:  D J Weber; W A Rutala; S A Kenyear; S M Lemon
Journal:  JAMA       Date:  1986-04-25       Impact factor: 56.272

4.  Low immune responses to hepatitis B vaccination among healthy subjects.

Authors:  P J Pead; A A Saeed; W G Hewitt; R N Brownfield
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

5.  Hepatitis B vaccine: low postvaccination immunity in hospital personnel given gluteal injections.

Authors:  K L Lindsay; D A Herbert; G L Gitnick
Journal:  Hepatology       Date:  1985 Nov-Dec       Impact factor: 17.425

  5 in total
  11 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Authors:  E Egea; A Iglesias; M Salazar; C Morimoto; M S Kruskall; Z Awdeh; S F Schlossman; C A Alper; E J Yunis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

Review 3.  Hepatitis B vaccination during pregnancy for preventing infant infection.

Authors:  Ussanee S Sangkomkamhang; Pisake Lumbiganon; Malinee Laopaiboon
Journal:  Cochrane Database Syst Rev       Date:  2014-11-11

Review 4.  Hepatitis B virus: where do we stand and what is the next step for eradication?

Authors:  Haruki Komatsu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 5.  The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review.

Authors:  Nelson F Eng; Nitin Bhardwaj; Rebecca Mulligan; Francisco Diaz-Mitoma
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

6.  Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.

Authors:  Hong Zhao; Paul Kiptoo; Todd D Williams; Teruna J Siahaan; Elizabeth M Topp
Journal:  J Control Release       Date:  2009-09-12       Impact factor: 9.776

7.  Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

Authors:  Peter Vink; Masanari Shiramoto; Masayuki Ogawa; Masahiro Eda; Martine Douha; Thomas Heineman; Himal Lal
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

8.  The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route.

Authors:  Robert Edelman; Meagan E Deming; Franklin R Toapanta; Mark D Heuser; Lisa Chrisley; Robin S Barnes; Steven S Wasserman; William C Blackwelder; Barry S Handwerger; Marcela Pasetti; Khan M Siddiqui; Marcelo B Sztein
Journal:  Immun Ageing       Date:  2020-04-28       Impact factor: 6.400

Review 9.  2019 meeting of the global virus network.

Authors:  Ramesh Akkina; Robert Garry; Christian Bréchot; Heinz Ellerbrok; Hideki Hasegawa; Luis Menéndez-Arias; Natalia Mercer; Johan Neyts; Victor Romanowski; Joaquim Segalés; Anders Vahlne
Journal:  Antiviral Res       Date:  2019-11-04       Impact factor: 5.970

Review 10.  Host responses from innate to adaptive immunity after vaccination: molecular and cellular events.

Authors:  Sang-Moo Kang; Richard W Compans
Journal:  Mol Cells       Date:  2009-02-05       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.